Lactate peak in muscle disclosed by magnetic resonance spectroscopy in a patient with CPEO-plus syndrome

Herbers, 2019, Tissue specific differences in mitochondrial DNA maintenance and expression, Mitochondrion, 44, 85, 10.1016/j.mito.2018.01.004 Muraresku, 2018, Mitochondrial disease: advances in clinical diagnosis, management, therapeutic development, and preventative strategies, Curr. Genetic Med. Rep., 6, 62, 10.1007/s40142-018-0138-9 Krššák, 2021, Proton magnetic resonance spectroscopy in skeletal muscle: Experts’ consensus recommendations, NMR Biomed., 34, 10.1002/nbm.4266 Yamasaki, 2005, Detection and differentiation of lactate and lipids by single-voxel proton MR spectroscopy, Neurosurg. Rev., 28, 267, 10.1007/s10143-005-0398-1 Niu, 2017, Mitochondrial dysfunction and cerebral metabolic abnormalities in patients with mitochondrial encephalomyopathy subtypes: evidence from proton MR spectroscopy and muscle biopsy, CNS Neurosci. Ther., 23, 686, 10.1111/cns.12714 Lee, 2018, Correlation of serum biomarkers and magnetic resonance spectroscopy in monitoring disease progression in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes due to mtDNA A3243G mutation, Front. Neurol., 9, 621, 10.3389/fneur.2018.00621